Congratulations to Genome Biologics for receiving €2.42 million from Horizon 2020 for their project “Reducing the cost, time, and ethical burden of preclinical research in the pharmaceutical industry." #EFRO bit.ly/2Q2giHG

Ons netwerk event de Warande in samenwerking met @architectsinmotion is een groot succes. Bedankt ozark henry voor het uitzonderlijke concert! #lifesciences #healthcare #network #venturecapital

Where better to meet than in beautiful Copenhagen BioEurope? For meeting requests please contact us at [email protected] EBD Group #BIOEurope #lifescience #biotech #venturecapital

We’re kaj copenhagen for #BioEurope2018 EBD Group. Get in touch to schedule a meeting with Dirk Reyn, managing partner bioqubeventures #VC #venturecapital #lifescience #biotech

Thank you @Annbelien for your kind words flanders.bio's first Deep Dive Event on our role in the creation of Rejuvenate Biomed #businessdevelopment #VC #VentureCapital #innovation #Healthcare

België is bij de wereldtop in medische biotechnologie. De Tijd brengt het hele ecosysteem in kaart. multimedia.tijd.be/biotechrevolut… Door Thomas Roelens saar sinnaeve Thomas Segers via De Tijd | #biotech #pharma

As the year comes to an end, we would like to thank you for your continued friendship and support. We wish you all a Merry Christmas and many successes in the new year! #happyholidays #newyear #newopportunities

Debora Dumont (bioqubeventures) joins the jury panel for our 10th edition of the #BIotechSMEAwards Are you an innovative #biotech #SME based in the EU? ➡️ Apply here:ow.ly/c0cK50vhQUt ➡️ Meet this years jury: ow.ly/kELx50vhQVs

Vic Swerts investeert in nieuw biotechfonds bit.ly/3fa6UxH

De Limburgse durfkapitalist Bioqube Ventures bracht 60 miljoen euro bijeen voor de ontwikkeling van medicijnen op basis van biotechnologie. trends.knack.be/economie/bedri…

Bioqube Ventures launches Bioqube Factory Fund I (bioqubeventures) flanders.bio/en/news/bioqub…

Bioqube haalt 60 miljoen op voor investeringen in biotech knack.be/s/r/c/1608477 via @kanaalZ

Genmab will be a strategic investor in Bioqube Factory Fund I, a new early stage venture capital fund focused on the development of therapeutics assets and technology platforms in Europe. #Innovation bioqubeventures

Delighted to welcome Anavo Therapeutics to our portfolio!

Egle Therapeutics nabs $46M as it looks to push into the clinic with next-gen Tregs platform fiercebiotech.com/biotech/egle-t…

Metrion Biosciences are delighted to announce today a collaboration on a venture creation project with bioqubeventures to identify novel #ionchannel inhibitors for #autoimmunediseases read more here: metrionbiosciences.com/metrion-biosci…

Congrats to the #Enhanc3dGenomics team on the official opening of the new facilities!